Cover Image
市場調查報告書

眼內炎:全球臨床實驗檢討

Endophthalmitis Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 177210
出版日期 內容資訊 英文 56 Pages
訂單完成後即時交付
價格
Back to Top
眼內炎:全球臨床實驗檢討 Endophthalmitis Global Clinical Trials Review, H2, 2014
出版日期: 2014年11月28日 內容資訊: 英文 56 Pages
簡介

是眼球內部的感染病。一般眼球內部是密封、無菌狀態的,外部的微生物無法入侵。但由於眼球內組織極度纖細,眼內炎相當嚴重,會有失明或失去眼睛的可能性。

本報告提供眼內炎的治療藥相關之臨床實驗調查分析,提供您臨床實驗數及受驗人數,各階段及Phase狀況,有潛力企業,正在開發的治療藥的資訊,臨床實驗簡介等相關的系統性資訊。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中東·非洲的主要國家

G7各國的臨床實驗:感染性疾病臨床實驗上眼內炎所佔的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:各階段

E7各國的臨床實驗:感染性疾病臨床實驗上眼內炎所佔的比例

E7各國的臨床實驗:Phase別

E7各國的臨床實驗:各階段

各方面的臨床實驗

各階段臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對象

贊助商類別臨床實驗

有潛力的贊助商

  • 眼內炎的治療藥臨床實驗的主要參與企業

有潛力藥物

臨床實驗簡介

  • 主要大學·研究機關·醫院臨床實驗概要
    • Royal Berkshire NHS Foundation Trust
    • CHU Dijon
    • Arak University of Medical Sciences
    • Erasmus MC
    • Zhejiang University
    • University of Chicago
    • National Eye Institute
    • Queen's University
    • Stanford University
    • Vanderbilt University

主要的臨床簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2436CTIDB

GlobalData's clinical trial report, "Endophthalmitis Global Clinical Trials Review, H2, 2014" provides data on the Endophthalmitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Endophthalmitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Endophthalmitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Endophthalmitis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Endophthalmitis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Endophthalmitis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Endophthalmitis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Drugs
  • Clinical Trial Overview of Top Institutes / Government
    • Royal Berkshire NHS Foundation Trust
    • Clinical Trial Overview of Royal Berkshire NHS Foundation Trust
    • CHU Dijon
    • Clinical Trial Overview of CHU Dijon
    • Arak University of Medical Sciences
    • Clinical Trial Overview of Arak University of Medical Sciences
    • Erasmus MC
    • Clinical Trial Overview of Erasmus MC
    • Zhejiang University
    • Clinical Trial Overview of Zhejiang University
    • University of Chicago
    • Clinical Trial Overview of University of Chicago
    • National Eye Institute
    • Clinical Trial Overview of National Eye Institute
    • Queen's University
    • Clinical Trial Overview of Queen's University
    • Stanford University
    • Clinical Trial Overview of Stanford University
    • Vanderbilt University
    • Clinical Trial Overview of Vanderbilt University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Endophthalmitis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Endophthalmitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Endophthalmitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Endophthalmitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Endophthalmitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Endophthalmitis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Endophthalmitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Endophthalmitis to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Endophthalmitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Endophthalmitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Endophthalmitis to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Endophthalmitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Endophthalmitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Endophthalmitis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Endophthalmitis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Endophthalmitis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Endophthalmitis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Endophthalmitis Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Endophthalmitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Endophthalmitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Endophthalmitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Endophthalmitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Berkshire NHS Foundation Trust, 2014*
  • Endophthalmitis Therapeutics Clinical Trials Market, Global, Clinical Trials by CHU Dijon, 2014*
  • Endophthalmitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Arak University of Medical Sciences, 2014*
  • Endophthalmitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014*
  • Endophthalmitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zhejiang University, 2014*
  • Endophthalmitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2014*
  • Endophthalmitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2014*
  • Endophthalmitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2014*
  • Endophthalmitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014*
  • Endophthalmitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2014*

List of Figures

  • Endophthalmitis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Endophthalmitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Endophthalmitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Endophthalmitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Endophthalmitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Endophthalmitis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Endophthalmitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Endophthalmitis to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Endophthalmitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Endophthalmitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Endophthalmitis to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Endophthalmitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Endophthalmitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Endophthalmitis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Endophthalmitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Endophthalmitis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Endophthalmitis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Endophthalmitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Endophthalmitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Endophthalmitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top